This public workshop is the first in a two-part series that examines the innovations needed to meet the targets for ending tuberculosis (TB) set by the WHO END TB Strategy for 2030. With support from the U.S. Agency for International Development (USAID), “Innovations for Tackling Tuberculosis in the Time of COVID-19” will feature presentations and discussions that will consider the development of affordable point-of-care tuberculosis diagnostic tests, improvements in TB care, how to utilize the existing TB platform in low-to-middle-income countries to address COVID-19 and other airborne infections in order to prevent future pandemics, and how to ensure increased and sustained commitments to reach the goal of ending TB in high burden countries despite the challenges from COVID-19.

The first session of this series will provide an update on the current status, unmet needs, and promising advances in diagnostics, vaccines and therapeutics, and the critical need for new business models in sustainably combating TB.

Register here: https://www.eventbrite.com/e/innovations-for-tackling-tuberculosis-in-the-time-of-covid-19-part-1-tickets-160974973479